[HTML][HTML] Potential of natural products in combination with arsenic trioxide: investigating cardioprotective effects and mechanisms
J Wang, YM Liu, J Hu, C Chen - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Over the past few decades, clinical trials conducted worldwide have demonstrated the
efficacy of arsenic trioxide (ATO) in the treatment of relapsed acute promyelocytic leukemia …
efficacy of arsenic trioxide (ATO) in the treatment of relapsed acute promyelocytic leukemia …
Health benefits of spices in individuals with chemotherapeutic drug-induced cardiotoxicity
J Liu, Q Zhang, T Tao, LY Wang, JY Sun, CJ Wu… - Current Opinion in …, 2022 - Elsevier
Cardio-oncology is an emerging field that mainly focuses on a series of cardiovascular
diseases caused by chemotherapy and radiotherapy. In the history and culture of human …
diseases caused by chemotherapy and radiotherapy. In the history and culture of human …
Arsenic trioxide-induced cardiotoxicity triggers ferroptosis in cardiomyoblast cells
L Wang, S Liu, C Gao, H Chen, J Li… - Human & …, 2022 - journals.sagepub.com
Arsenic trioxide (ATO) has been found to be effective in acute promyelocytic leukemia.
However, ATO-induced severe cardiotoxicity limits its clinical application. To date, the …
However, ATO-induced severe cardiotoxicity limits its clinical application. To date, the …
[HTML][HTML] A newly synthesized flavone avoids COMT-catalyzed methylation and mitigates myocardial ischemia/reperfusion injury in H9C2 cells via JNK and P38 …
Y Lin, X Yang, Y Li, D Huang, Z Sun - Iranian Journal of Basic …, 2024 - ncbi.nlm.nih.gov
Objective (s): Luteolin is a flavone that provides defense against myocardial
ischemia/reperfusion (I/R) injury. However, this compound is subjected to methylation …
ischemia/reperfusion (I/R) injury. However, this compound is subjected to methylation …
Interlinking Leukemia Cell Lines with Clinicopathological Therapeutics: Exploring Eugenol's Anti-Cancer Potential for Leukemia and Its Types: Exploring Eugenol's …
The clove oil contains a bioactive compound, eugenol, which holds promise as a therapeutic
agent in cancer treatment, such as leukemia. Objectives: To represent eugenol's …
agent in cancer treatment, such as leukemia. Objectives: To represent eugenol's …